MyFinsight
Home
Blog
About
Effects of exchange rate
changes on cash and cash...
$7K
(-88.71%↓ Y/Y)
Net increase
(decrease) in cash and cash...
-$3,095K
(-771.37%↓ Y/Y)
Canceled cashflow
$7K
Accounts payable
$389K
(229.24%↑ Y/Y)
Accrued expenses
$223K
(137.04%↑ Y/Y)
Stock-based compensation
$135K
(-50.55%↓ Y/Y)
Non-cash lease expense
$111K
(-55.42%↓ Y/Y)
Accrued employee
benefits
$25K
(105.85%↑ Y/Y)
Depreciation
$24K
(-54.72%↓ Y/Y)
Net cash used in
operating activities
-$3,085K
(67.42%↑ Y/Y)
Net cash provided by
financing activities
-$14K
(-100.14%↓ Y/Y)
Canceled cashflow
$907K
Net cash used in
investing activities
-$3K
(81.25%↑ Y/Y)
Net loss
-$3,217K
(81.49%↑ Y/Y)
Payment of loans payable
-$11K
(83.58%↑ Y/Y)
Tax credit
receivable
-$3K
(-100.17%↓ Y/Y)
Deferred research and
development tax credit
-$415K
(51.23%↑ Y/Y)
Change in fair value of
contingent consideration
-$212K
(-102.31%↓ Y/Y)
Operating lease liability
-$122K
(54.48%↑ Y/Y)
Prepaid expenses and
other current assets
$26K
(104.23%↑ Y/Y)
Purchase of property and
equipment
$3K
(-81.25%↓ Y/Y)
Back
Back
Cash Flow
Theriva Biologics, Inc. (TOVX)
Theriva Biologics, Inc. (TOVX)
source: myfinsight.com